Correction: Receptor tyrosine kinase inhibitor sunitinib as novel immunotherapy to inhibit myeloid-derived suppressor cells for treatment of endometriosis.
Saved in:
| Title: | Correction: Receptor tyrosine kinase inhibitor sunitinib as novel immunotherapy to inhibit myeloid-derived suppressor cells for treatment of endometriosis. |
|---|---|
| Authors: | He Y; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Hung SW; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Liang B; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Zhang R; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Gao Y; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Chu CY; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Zhang T; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Xu H; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Chung JPW; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China., Wang CC; Department of Obstetrics & Gynaecology, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.; School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China.; Chinese University of Hong Kong-Sichuan University Joint Laboratory in Reproductive Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Nov 24; Vol. 16, pp. 1741271. Date of Electronic Publication: 2025 Nov 24 (Print Publication: 2025). |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1741271 |
